Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$88.33 USD

88.33
5,230,398

-0.47 (-0.53%)

Updated Aug 28, 2024 04:00 PM ET

Pre-Market: $88.40 +0.07 (0.08%) 9:26 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 251)

Industry: Medical - Products

Better trading starts here.

Balance Sheet

Research for MDT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Medtronic PLC falls in the month of April.

All items in Millions except Per Share data.

4/30/2024 4/30/2023 4/30/2022 4/30/2021 4/30/2020
Assets          
Cash & Equivalents 8,005 7,959 10,573 10,817 10,948
Receivables 6,128 5,998 5,551 5,462 4,645
Notes Receivable 0 0 0 0 0
Inventories 5,217 5,293 4,616 4,313 4,229
Other Current Assets 2,584 2,425 2,318 1,955 2,209
Total Current Assets 21,935 21,675 23,059 22,548 22,031
Net Property & Equipment 6,131 5,569 5,413 5,221 4,828
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3,657 3,477 3,403 3,169 2,832
Intangibles 54,211 56,269 56,097 59,701 58,904
Deposits & Other Assets 4,047 3,959 3,008 2,443 2,094
Total Assets 89,981 90,948 90,981 93,083 90,689
Liabilities & Shareholders Equity 4/30/2024 4/30/2023 4/30/2022 4/30/2021 4/30/2020
Notes Payable 0 0 0 0 0
Accounts Payable 2,410 2,662 2,276 2,106 1,996
Current Portion Long-Term Debt 1,092 20 3,742 11 2,776
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5,957 5,530 5,672 5,957 5,092
Income Taxes Payable 1,330 840 704 435 502
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 10,789 9,051 12,394 8,509 10,366
Mortgages 0 0 0 0 0
Deferred Taxes/Income 515 708 884 1,028 1,174
Convertible Debt 0 0 0 0 0
Long-Term Debt 23,932 24,344 20,372 26,378 22,021
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 4,325 5,180 4,610 5,564 6,256
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 39,561 39,283 38,260 41,481 39,817
Shareholders Equity 4/30/2024 4/30/2023 4/30/2022 4/30/2021 4/30/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 23,129 24,590 24,566 26,319 26,165
Retained Earnings 30,403 30,392 30,250 28,594 28,132
Other Equity -3,112 -3,317 -2,094 -3,311 -3,425
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 50,420 51,665 52,722 51,602 50,872
Total Liabilities & Shareholder's Equity 89,981 90,948 90,981 93,083 90,689
Total Common Equity 50,420 51,665 52,722 51,602 50,872
Shares Outstanding 1,327.82 1,330.42 1,341.50 1,348.00 1,340.10
Book Value Per Share 37.97 38.83 39.30 38.28 37.96

Fiscal Year End for Medtronic PLC falls in the month of April.

All items in Millions except Per Share data.

7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023
Assets          
Cash & Equivalents 7,843 8,005 8,321 7,734 7,876
Receivables 6,011 6,128 5,968 5,934 5,806
Notes Receivable NA 0 0 0 0
Inventories 5,414 5,217 5,726 5,754 5,668
Other Current Assets 2,679 2,584 2,499 2,658 2,518
Total Current Assets 21,947 21,935 22,513 22,081 21,869
Net Property & Equipment 6,282 6,131 5,838 5,735 5,665
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges 3,554 3,657 3,599 3,428 3,461
Intangibles 53,903 54,211 54,850 54,881 55,870
Deposits & Other Assets 4,062 4,047 4,036 3,962 3,912
Total Assets 89,749 89,981 90,836 90,087 90,776
Liabilities & Shareholders Equity 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable 2,291 2,410 1,992 2,174 2,239
Current Portion Long-Term Debt 1,553 1,092 1,029 1,339 519
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses 5,380 5,957 5,662 5,057 5,276
Income Taxes Payable 1,063 1,330 1,109 1,088 1,013
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities 10,287 10,789 9,793 9,659 9,047
Mortgages NA 0 0 0 0
Deferred Taxes/Income 496 515 615 686 687
Convertible Debt NA 0 0 0 0
Long-Term Debt 26,312 23,932 24,153 23,741 24,463
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 4,494 4,280 4,353 5,214
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 41,589 39,561 38,840 38,440 39,410
Shareholders Equity 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus 20,810 23,129 24,589 24,580 24,587
Retained Earnings 30,547 30,403 30,661 30,256 30,265
Other Equity -3,197 -3,112 -3,255 -3,190 -3,486
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 48,160 50,420 51,996 51,647 51,366
Total Liabilities & Shareholder's Equity 89,749 89,981 90,836 90,087 90,776
Total Common Equity 148,159 50,420 51,996 51,647 51,366
Shares Outstanding 1,282.60 1,327.82 1,327.80 1,329.60 1,330.50
Book Value Per Share 115.51 37.97 39.16 38.84 38.61